Standard Biotools (LAB) EBIT Margin (2010 - 2026)
Standard Biotools' (LAB) quarterly EBIT Margin came in at 126.28% in Q2 2026, down 820.0% year-over-year from 17.54% in Q2 2025, and down 113.7% quarter-over-quarter from 59.09% in Q1 2026.
Powered by 
Analysis
Standard Biotools (LAB) EBIT Margin (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported EBIT Margin for 17 consecutive years, with 126.28% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBIT Margin fell 820.0% year-over-year to 126.28% in Q2 2026; TTM through Jun 2026 was 112.85%, a 584.0% increase from a year earlier, with the FY2025 full-year figure at 129.2%, up 1088.0% from the prior year.
- EBIT Margin was 126.28% for Q2 2026 at Standard Biotools, down from 59.09% in the prior quarter.
- Over five years, EBIT Margin peaked at 59.09% in Q1 2026 and troughed at 205.37% in Q2 2022.
- A 5-year average of 110.59% and a median of 109.23% in 2022 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin tumbled 14804 bps in 2022 and soared 14230 bps in 2023, its largest moves.
- Over 5 years, EBIT Margin stood at 78.13% in 2022, then rose by 3 bps to 75.87% in 2023, then plunged by 39 bps to 105.27% in 2024, then gained by 2 bps to 103.57% in 2025, then fell by 22 bps to 126.28% in 2026.
- The last three EBIT Margin figures came in at 126.28% (Q2 2026), 59.09% (Q1 2026), and 103.57% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.12 Bn | 221.06 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 144.34 Bn | 139.99 Bn | 3.61 Bn | 17.99% |
| 3 | Agilent Technologies | 41.01 Bn | 39.25 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 31.14 Bn | 29.97 Bn | 770.00 Mn | 21.14% |
| 5 | Revvity | 13.89 Bn | 12.86 Bn | 416.87 Mn | 12.24% |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | 23.13% |
| 7 | Bio-Rad Laboratories | 10.13 Bn | 8.51 Bn | 345.80 Mn | 11.15% |
| 8 | Repligen | 9.34 Bn | 8.33 Bn | 110.04 Mn | 6.85% |
| 9 | 10x Genomics | 8.67 Bn | 8.12 Bn | 112.50 Mn | -12.95% |
| 10 | Standard Biotools | 282.29 Mn | -194.42 Mn | 10.54 Mn | -126.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -126.28% |
| Mar 31, 2026 | -59.09% |
| Dec 31, 2025 | -103.57% |
| Sep 30, 2025 | -168.46% |
| Jun 30, 2025 | -118.08% |
| Mar 31, 2025 | -133.37% |
| Dec 31, 2024 | -105.27% |
| Sep 30, 2024 | -120.89% |
| Jun 30, 2024 | -134.54% |
| Mar 31, 2024 | -132.15% |
| Dec 31, 2023 | -75.87% |
| Sep 30, 2023 | -83.46% |
| Jun 30, 2023 | -63.07% |
| Mar 31, 2023 | -66.06% |
| Dec 31, 2022 | -78.13% |
| Sep 30, 2022 | -113.18% |
| Jun 30, 2022 | -205.37% |
| Mar 31, 2022 | -103.77% |
| Sep 30, 2021 | -60.88% |
| Jun 30, 2021 | -57.34% |